Human whole-body biodistribution and dosimetry of a new PET tracer, [11C]ketoprofen methyl ester, for imagings of neuroinflammation
- 1 August 2014
- journal article
- clinical trial
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 41 (7) , 594-599
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
- Japan Science and Technology Agency
This publication has 9 references indexed in Scilit:
- Current paradigm of the 18-kDa translocator protein (TSPO) as a molecular target for PET imaging in neuroinflammation and neurodegenerative diseasesInsights into Imaging, 2011
- In Vivo Expression of Cyclooxygenase-1 in Activated Microglia and Macrophages During Neuroinflammation Visualized by PET with 11C-Ketoprofen Methyl EsterJournal of Nuclear Medicine, 2011
- General Method for the 11C‐Labeling of 2‐Arylpropionic Acids and Their Esters: Construction of a PET Tracer Library for a Study of Biological Events Involved in COXs ExpressionChemistry – A European Journal, 2010
- PET Imaging of the Peripheral Benzodiazepine Receptor: Monitoring Disease Progression and Therapy Response in Neurodegenerative DisordersCurrent Pharmaceutical Design, 2008
- Interactions between APP secretases and inflammatory mediatorsJournal of Neuroinflammation, 2008
- The peripheral benzodiazepine receptor (Translocator protein 18kDa) in microglia: From pathology to imagingProgress in Neurobiology, 2006
- Kinetic Modeling of Amyloid Binding in Humans using PET Imaging and Pittsburgh Compound-BJournal of Cerebral Blood Flow & Metabolism, 2005
- Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's DiseaseNew England Journal of Medicine, 2001
- Cyclooxygenase-1 in Human Alzheimer and Control Brain: Quantitative Analysis of Expression by Microglia and CA3 Hippocampal NeuronsJournal of Neuropathology & Experimental Neurology, 1999